SCHMIDT ERIC THOMAS
SEC CIK 1754403 · EDGAR
BoughtSold
Most active insiders at RVMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GOLDSMITH MARK A | See Remarks, Dir | — | $56.99M |
| 2 | Kelsey Stephen Michael | See Remarks | — | $22.55M |
| 3 | Cislini Jeff | SVP, GC | — | $15.11M |
| 4 | Kim Lorence H. | Dir | — | $14.97M |
| 5 | Horn Margaret A | COO | — | $10.84M |
| 6 | Mancini Anthony | See Remarks | — | $9.05M |
| 7 | Anders Jack | CFO | — | $7.13M |
| 8 | ANDERSON ELIZABETH M | Dir | — | $1.96M |
| 9 | Patel Sushil | Dir | — | $1.05M |
| 10 | Wei Lin | Chief Medical Off | — | $206.2K |
SCHMIDT ERIC THOMAS made no open-market trades at RVMD in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-12 | 2023-06-08 | RVMD | Revolution Medicines, Inc. | SCHMIDT ERIC THOMAS | Dir | A - Grant | $0.00 | +5,200 | 21.3K | +32% | $0 |
| D | 2023-03-24 | 2023-03-22 | ALLO | Allogene Therapeutics, Inc. | SCHMIDT ERIC THOMAS | CFO | A - Grant | $0.00 | +558.1K | 862.4K | +183% | $0 |
| 2023-03-16 | 2023-03-14 | ALLO | Allogene Therapeutics, Inc. | SCHMIDT ERIC THOMAS | CFO | F - Tax | $5.47 | -35.9K | 304.3K | -11% | -$196.3K | |
| D | 2022-06-17 | 2022-06-16 | RVMD | Revolution Medicines, Inc. | SCHMIDT ERIC THOMAS | Dir | A - Grant | $0.00 | +5,200 | 16.1K | +48% | $0 |
| D | 2022-03-25 | 2022-03-23 | ALLO | Allogene Therapeutics, Inc. | SCHMIDT ERIC THOMAS | CFO | A - Grant | $0.00 | +237.4K | 337.9K | +236% | $0 |
| 2022-03-17 | 2022-03-15 | ALLO | Allogene Therapeutics, Inc. | SCHMIDT ERIC THOMAS | CFO | S - Sale | $7.63 | -11.5K | 100.5K | -10% | -$87.5K |
Purchase Sale Sale after option exercise All abbreviations